Treatment of Diabetic Macular Edema With Aflibercept in Subjects Previously Treated With Ranibizumab or Bevacizumab
Status:
Completed
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
Treatment of diabetic macular edema with intravitreal aflibercept in subjects previously
treated with intravitreal anti-Vegf agents (ranibizumab or bevacizumab)